BRTXVSCMMB• 3 Months (Normalized)
BRTX vs CMMB (BioRestorative Therapies Inc. Common Stock (NV) vs Chemomab Therapeutics Ltd.)
Showing Closing Date Range from Jul 2 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BRTX Performance $2.31
+%
BioRestorative Therapies Inc. Common Stock (NV)
Normalized Baseline0.00%
CMMB Performance $1.67
-26.43%
Chemomab Therapeutics Ltd.
Normalized Baseline0.00%
Alpha Spread Margin BRTX LEADS
+26.43 pts
BRTX outperforming by 26.43 percentage points
BRTXCMMB
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BRTX CMMB
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(62 dates)
| Date | BRTX Price | BRTX Gain (%) | CMMB Price | CMMB Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $- | $1.67 | -26.43% | - | |
| Sep 28, 2026 | $2.31 | +477.50% | $1.64 | -27.75% | +505.25% |
| Sep 25, 2026 | $2.55 | +537.50% | $2.16 | -4.85% | +542.35% |
| Sep 24, 2026 | $2.51 | +527.50% | $2.20 | -3.08% | +530.58% |
| Sep 23, 2026 | $2.60 | +550.00% | $2.28 | +0.44% | +549.56% |
| Sep 22, 2026 | $2.55 | +537.50% | $2.51 | +10.57% | +526.93% |
| Sep 21, 2026 | $2.71 | +577.50% | $2.48 | +9.25% | +568.25% |
| Sep 18, 2026 | $2.69 | +572.50% | $2.61 | +14.98% | +557.52% |
| Sep 17, 2026 | $2.66 | +563.75% | $2.80 | +23.35% | +540.40% |
| Sep 16, 2026 | $2.55 | +537.50% | $2.65 | +16.74% | +520.76% |
| Sep 15, 2026 | $2.64 | +560.00% | $2.47 | +8.81% | +551.19% |
| Sep 14, 2026 | $2.70 | +575.00% | $2.45 | +7.93% | +567.07% |
| Sep 11, 2026 | $2.67 | +567.50% | $2.58 | +13.66% | +553.84% |
| Sep 10, 2026 | $2.76 | +590.00% | $2.60 | +14.54% | +575.46% |
| Sep 09, 2026 | $2.74 | +585.00% | $2.69 | +18.50% | +566.50% |
Page 1 of 5